Literature DB >> 31637585

Gender Differences in Arrhythmias: Focused on Atrial Fibrillation.

Xiao-Ting Tian1, Ying-Jia Xu1, Yi-Qing Yang2.   

Abstract

There are significant differences in clinical presentation and treatment of atrial fibrillation (AF) between women and men. The primary goal of AF management is to restore sinus rhythm and to prevent various complications, including stroke and heart failure. In many areas of AF, such as prevalence, clinical manifestations, morbidity, risk factors, pathophysiology, treatment strategies, and complications, gender-specific variability is observed and needs to be further addressed by large-scale population researches or randomized clinical trials, which help to promote the customization of AF treatment programs, hence to maximize the success rate of AF therapy in both sexes. This review highlights our current understanding of these gender differences in AF and how these differences affect treatment decisions on AF.

Entities:  

Keywords:  Arrhythmia; Atrial fibrillation; Complication; Gender; Pathophysiology

Year:  2019        PMID: 31637585     DOI: 10.1007/s12265-019-09918-w

Source DB:  PubMed          Journal:  J Cardiovasc Transl Res        ISSN: 1937-5387            Impact factor:   4.132


  110 in total

1.  Sex-related differences in presentation, treatment, and outcome of patients with atrial fibrillation in Europe: a report from the Euro Observational Research Programme Pilot survey on Atrial Fibrillation.

Authors:  Gregory Y H Lip; Cécile Laroche; Giuseppe Boriani; Paolo Cimaglia; Gheorghe-Andrei Dan; Massimo Santini; Zbigniew Kalarus; Lars Hvilsted Rasmussen; Mircea Ioachim Popescu; Otilia Tica; Camilla Fragtrup Hellum; Bettina Mortensen; Luigi Tavazzi; Aldo P Maggioni
Journal:  Europace       Date:  2014-06-22       Impact factor: 5.214

Review 2.  2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society.

Authors:  Craig T January; L Samuel Wann; Joseph S Alpert; Hugh Calkins; Joaquin E Cigarroa; Joseph C Cleveland; Jamie B Conti; Patrick T Ellinor; Michael D Ezekowitz; Michael E Field; Katherine T Murray; Ralph L Sacco; William G Stevenson; Patrick J Tchou; Cynthia M Tracy; Clyde W Yancy
Journal:  J Am Coll Cardiol       Date:  2014-03-28       Impact factor: 24.094

3.  Indirect Comparison of Novel Oral Anticoagulants in Women with Nonvalvular Atrial Fibrillation.

Authors:  Alex Moseley; Rami Doukky; Kim Allan Williams; Amir K Jaffer; Annabelle Santos Volgman
Journal:  J Womens Health (Larchmt)       Date:  2016-11-21       Impact factor: 2.681

4.  Effect of pregnancy on paroxysmal supraventricular tachycardia.

Authors:  M Tawam; J Levine; M Mendelson; J Goldberger; A Dyer; A Kadish
Journal:  Am J Cardiol       Date:  1993-10-01       Impact factor: 2.778

Review 5.  Left atrial appendage devices for stroke prevention in atrial fibrillation.

Authors:  Sarah K Hussain; Rohit Malhotra; John P DiMarco
Journal:  J Cardiovasc Transl Res       Date:  2014-05-01       Impact factor: 4.132

6.  Acute effects of sex steroid hormones on susceptibility to cardiac arrhythmias: a simulation study.

Authors:  Pei-Chi Yang; Junko Kurokawa; Tetsushi Furukawa; Colleen E Clancy
Journal:  PLoS Comput Biol       Date:  2010-01-29       Impact factor: 4.475

7.  Efficacy, safety, and outcomes of catheter ablation of atrial fibrillation in patients with heart failure with preserved ejection fraction.

Authors:  Tomoko Machino-Ohtsuka; Yoshihiro Seo; Tomoko Ishizu; Akinori Sugano; Akiko Atsumi; Masayoshi Yamamoto; Ryo Kawamura; Takeshi Machino; Kenji Kuroki; Hiro Yamasaki; Miyako Igarashi; Yukio Sekiguchi; Kazutaka Aonuma
Journal:  J Am Coll Cardiol       Date:  2013-07-31       Impact factor: 24.094

8.  Advanced Left Atrial Remodeling and Appendage Contractile Dysfunction in Women Than in Men Among the Patients With Atrial Fibrillation: Potential Mechanism for Stroke.

Authors:  Hee Tae Yu; Jihei Sara Lee; Tae-Hoon Kim; Jae-Sun Uhm; Boyoung Joung; Geu-Ru Hong; Moon-Hyoung Lee; Chi Young Shim; Hui-Nam Pak
Journal:  J Am Heart Assoc       Date:  2016-07-11       Impact factor: 5.501

Review 9.  Diabetes and Arrhythmias: Pathophysiology, Mechanisms and Therapeutic Outcomes.

Authors:  Laurel A Grisanti
Journal:  Front Physiol       Date:  2018-11-26       Impact factor: 4.566

10.  Gender differences in fibrosis remodeling in patients with long-standing persistent atrial fibrillation.

Authors:  Zhi Li; Zengwei Wang; Zongtao Yin; Yuji Zhang; Xiaodong Xue; Jinsong Han; Yan Zhu; Jian Zhang; Maximilian Y Emmert; Huishan Wang
Journal:  Oncotarget       Date:  2017-03-17
View more
  5 in total

1.  Editorial: Gender Differences in Cardiovascular Diseases.

Authors:  Qiulian Zhou; Yihua Bei
Journal:  J Cardiovasc Transl Res       Date:  2020-02       Impact factor: 4.132

2.  Death of a child and the risk of atrial fibrillation: a nationwide cohort study in Sweden.

Authors:  Dang Wei; Tristan Olofsson; Hua Chen; Imre Janszky; Fang Fang; Rickard Ljung; Yongfu Yu; Jiong Li; Krisztina D László
Journal:  Eur Heart J       Date:  2021-04-14       Impact factor: 29.983

3.  The Effects of Fibrotic Cell Type and Its Density on Atrial Fibrillation Dynamics: An In Silico Study.

Authors:  Laura C Palacio; Juan P Ugarte; Javier Saiz; Catalina Tobón
Journal:  Cells       Date:  2021-10-15       Impact factor: 6.600

4.  A novel PRRX1 loss-of-function variation contributing to familial atrial fibrillation and congenital patent ductus arteriosus.

Authors:  Zun-Ping Ke; Gao-Feng Zhang; Yu-Han Guo; Yu-Min Sun; Jun Wang; Ning Li; Xing-Biao Qiu; Ying-Jia Xu; Yi-Qing Yang
Journal:  Genet Mol Biol       Date:  2022-03-30       Impact factor: 1.771

5.  Particularities of Catheter Ablation in Women with Atrial Fibrillation and Associated Ischemic Heart Disease.

Authors:  Diana Andrada Irimie; Adela Viviana Sitar-Tăut; Bogdan Caloian; Florina Frîngu; Gabriel Cismaru; Radu Roşu; Mihai Puiu; Ioan Alexandru Minciună; Gelu Simu; Dumitru Zdrenghea; Dana Pop
Journal:  J Clin Med       Date:  2022-09-22       Impact factor: 4.964

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.